Kaul CL - Search Results

1

Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.

Jain M, Vangapandu S, Sachdeva S, Singh S, Singh PP, Jena GB, Tikoo K, Ramarao P, Kaul CL, Jain R. Jain M, et al. Among authors: kaul cl. J Med Chem. 2004 Jan 15;47(2):285-7. doi: 10.1021/jm0304562. J Med Chem. 2004. PMID: 14711300

2

Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.

Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS. Kabra DG, et al. Among authors: kaul cl. Brain Res Bull. 2004 Feb 1;62(5):425-33. doi: 10.1016/j.brainresbull.2003.11.001. Brain Res Bull. 2004. PMID: 15168908

3

Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.

Kumar S, Arun KH, Kaul CL, Sharma SS. Kumar S, et al. Among authors: kaul cl. Neurol Res. 2005 Jan;27(1):60-6. doi: 10.1179/016164105X18278. Neurol Res. 2005. PMID: 15829161

4

Combination of metformin and thiazolidindiones restore insulin signalling in insulin-resistant cultured myotubes.

Kumar N, Kaul CL, Ishrath A, Dey CS. Kumar N, et al. Among authors: kaul cl. Life Sci. 2004 Feb 27;74(15):1877-88. doi: 10.1016/j.lfs.2003.08.040. Life Sci. 2004. PMID: 14761669

5

Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.

Gupta S, Kaul CL, Sharma SS. Gupta S, et al. Among authors: kaul cl. Neurol Res. 2004 Jan;26(1):103-7. doi: 10.1179/016164104773026624. Neurol Res. 2004. PMID: 14977067

6

Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia.

Sharma SS, Munusamy S, Thiyagarajan M, Kaul CL. Sharma SS, et al. Among authors: kaul cl. J Neurosurg. 2004 Oct;101(4):669-75. doi: 10.3171/jns.2004.101.4.0669. J Neurosurg. 2004. PMID: 15481724

7

Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.

Viswanad B, Srinivasan K, Kaul CL, Ramarao P. Viswanad B, et al. Among authors: kaul cl. Pharmacol Res. 2006 Mar;53(3):209-15. doi: 10.1016/j.phrs.2005.11.002. Epub 2006 Jan 10. Pharmacol Res. 2006. PMID: 16412660

8

Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.

Panchagnula R, Bansal T, Varma MV, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. Pharmazie. 2005 Dec;60(12):922-7. Pharmazie. 2005. PMID: 16398269

9

Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations.

Agrawal S, Kaur KJ, Singh I, Bhade S, Kaul CL, Panchagnula R. Agrawal S, et al. Among authors: kaul cl. Int J Tuberc Lung Dis. 2005 Nov;9(11):1273-80. Int J Tuberc Lung Dis. 2005. PMID: 16333937

10

Quality control of anti-tuberculosis FDC formulations in the global market: part II-accelerated stability studies.

Ashokraj Y, Kohli G, Kaul CL, Panchagnula R. Ashokraj Y, et al. Among authors: kaul cl. Int J Tuberc Lung Dis. 2005 Nov;9(11):1266-72. Int J Tuberc Lung Dis. 2005. PMID: 16333936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters